Influence of (11)C-choline PET/CT on radiotherapy planning in prostate cancer.

Rep Pract Oncol Radiother

Radiotherapy and Oncology Department, ONCOSUR, Granada, Spain.

Published: April 2015

Aim: To evaluate the influence of (11)C-choline PET/CT on radiotherapy planning in prostate cancer patients.

Background: Precise information on the extension of prostate cancer is crucial for the choice of an appropriate therapeutic strategy. (11)C-choline positron emission tomography ((11)C-choline PET/CT) has two roles in radiation oncology (RT): (1) patient selection for treatment and (2) target volume selection and delineation. In conjunction with high-accuracy techniques, it might offer an opportunity of dose escalation and better tumour control while sparing healthy tissues.

Materials And Methods: We carried out a retrospective study in order to analyse RT planning modification based on (11)C-choline PET/CT in 16 prostate cancer patients. Patients were treated with hypofractionated step-and-shoot Intensity Modulated Radiotherapy (IMRT), or Volumetric Modulated Arc Therapy (VMAT), and a daily cone-beam CT for Image Guided Radiation Therapy (IGRT). All patients underwent a (11)C-choline-PET/CT scan prior to radiotherapy.

Results: In 37.5% of cases, a re-delineation and new dose prescription occurred. Data show good preliminary clinical results in terms of biochemical control and toxicity. No gastrointestinal (GI)/genitourinary (GU) grade III toxicities were observed after a median follow-up of 9.5 months.

Conclusions: In our experience, concerning the treatment of prostate cancer (PCa), (11)C-choline PET/CT may be helpful in radiotherapy planning, either for dose escalation or exclusion of selected sites.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4338287PMC
http://dx.doi.org/10.1016/j.rpor.2014.11.008DOI Listing

Publication Analysis

Top Keywords

11c-choline pet/ct
20
prostate cancer
20
radiotherapy planning
12
influence 11c-choline
8
pet/ct radiotherapy
8
planning prostate
8
dose escalation
8
pet/ct
5
prostate
5
cancer
5

Similar Publications

Article Synopsis
  • The study aimed to assess the pathological implications of focal thyroid uptake observed in 11C-Choline PET/CT scans for prostate cancer patients.
  • Researchers reviewed records of male patients who underwent these scans between 2018 and 2021, excluding those with prior thyroid interventions or conditions that could skew results.
  • Out of 103 patients with focal thyroid uptake, the majority were evaluated with ultrasound, leading to the conclusion that most nodules were benign, but some malignancies were identified, indicating no significant difference in standardized uptake values between benign and malignant nodules.
View Article and Find Full Text PDF

Endocrinology application of molecular imaging: current role of PET/CT.

J Endocrinol Invest

October 2024

Nuclear Medicine Division, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico di S. Orsola, Via Albertoni 15, Bologna, Italy.

Background: In recent years, nuclear medicine imaging methods have proven to be of paramount importance in a wide variety of diseases, particularly in oncology, where they are crucial for assessing the extent of disease when conventional methods fall short. Moreover, nuclear imaging modalities are able to better characterize lesions using target agents related to specific pathways (e.g.

View Article and Find Full Text PDF

To compare the diagnostic efficacy of C-choline PET/CT, neck ultrasonography, Tc-MIBI dual-phase planar scintigraphy, and Tc-MIBI SPECT/CT imaging in the diagnosis of primary hyperparathyroidism (PHPT). We conducted a retrospective analysis of 32 patients with PHPT who visited the Nuclear Medicine Department of Jilin University China-Japan Union Hospital between January 2019 and December 2022. All patients underwent C-choline PET/CT, neck ultrasonography, Tc-MIBI dual-phase planar scintigraphy, and Tc-MIBI SPECT/CT examinations within two months before surgery.

View Article and Find Full Text PDF

A 79-year-old man with prostate cancer (PCa) was referred to our center to perform a [C]Choline PET/CT for biochemical recurrence. Positron emission tomography/computed tomography (PET/CT) scan detected PCa recurrence in the prostate gland and several pelvic and abdominal lymph nodes. Two abnormal uptakes were also identified in the right breast and in the liver, respectively.

View Article and Find Full Text PDF

Aims: To report long-term outcomes of relapsed prostate cancer (PC) patients treated in a prospective single-arm study with extended-nodal radiotherapy (ENRT) and [11C]-choline positron emission tomography (PET)/computed tomography (CT)-guided simultaneous integrated boost (SIB) to positive lymph nodes (LNs).

Methods: From 12/2009 to 04/2015, 60 PC patients with biochemical relapse and positive LNs only were treated in this study. ENRT at a median total dose (TD) = 51.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!